Megafine Pharma (P) Ltd is an innovative and integrated manufacturer of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates, catering to both Innovators and Generic companies. The company is certified by multiple global regulatory bodies including USFDA, EU-GMP, Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA, and Mexico-COFEPRIS. With a robust portfolio comprising 26 US-DMFs, 6 CEPs, and over 350 global regulatory filings, Megafine Pharma continually advances its capabilities, recently commissioning a new API plant in Vapi featuring five production blocks. Recent validations include Apremilast, Edoxaban, Cariprazine, Teriflunomide, and Vortioxetine, while new development initiatives include Vibegron.

Services include:
- Regulatory Services
- APIs (Active Pharmaceutical Ingredients)
- Drug delivery devices

As a leading entity in the pharmaceutical industry, Megafine Pharma (P) Ltd is dedicated to delivering high-quality products and services tailored to the needs of its clients. For further information, please visit megafine.in.